SII, Bharat Biotech jointly pledge to work for smooth roll out of COVID-19 vaccines
They said that the important task in front of them is saving the lives and livelihoods of populations in India and the world
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
COVID-19 Updates
Trane Technologies’ Thermo King launches cold chain solutions for COVID-19 vaccines in India
Thermo King’s SuperFreezers offer transport and storage of vaccines from a pharma company to the inoculation site by maintaining…
Bharat Biotech to make 700 million doses in 2021
Dr Krishna Ella, Chairman and MD Bharat Biotech said that Covaxin trials '200 per cent honest'
Mixed reactions from healthcare experts, activists over REU for Covaxin, Covishield
Some ask for more transparency in the approval process and seek data related to vaccine trials while others say that grant of REU…
US may halve doses of Moderna vaccine to speed rollout: Moncef Slaoui
Moncef Slaoui, Head of Operation Warp Speed, said that officials were in talks with Moderna and the Food and Drug Administration…
Brazilian Clinics plans deal with Bharat Biotech for five million doses of Covaxin
A team from ABCVAC will travel to India for further discussions with Bharat Biotech, as per reports
Drug activist group AIDAN raises concerns over EUA for COVAXIN
Urging the DCGI to reconsider the recommendations of the SEC in granting the REU approval to COVAXIN, it has aked the drug…
Zydus Cadila gets DCGI approval for Phase Ill trial of ZyCoV-D
The company will now be initiating Phase III clinical trial in around 30,000 volunteers
DCGI approves Covishield and Covaxin for restricted emergency use in India
DCGI’s decision comes after the Subject Expert Committee of CDSCO met on January 1-2, 2021 and recommended the grant of permission…
NSRT to start Phase II trial of Eflornithine granules to treat COVID-19 by early Jan 2021
The company aims to complete the study by March 2021
HMD gets WHO-PQS certification for 0.3 ml Kojak AD Syringe, required for Pfizer’s vaccine
The company supplies to the UN Agencies like UNICEF, UNOPS for and is also manufactures auto disable syringes for curative…
COVAXIN clinical trials recruit 23,000 subjects
COVAXIN has been evaluated in approximately 1000 subjects in Phase I and Phase II clinical trials, with promising safety and…
SEC recommends EUA for Covaxin from Bharat Biotech
The expert panel deliberated on Bharat Biotech’s EUA application after it submitted additional data, facts and analysis after…
SEC recommends EUA for Covishield, DCGI nod awaited
The SEC is also looking at the EUA applications of Pfizer and Bharat Biotech
CBIC relaxes rules for courier import and export of COVID-19 vaccines
Also instructs customs authorities to form a task force to enable speedy customs clearance of COVID-19 vaccines
Dry run for COVID-19 vaccine roll out in all States/UTs on January 2, 2021
The activity is proposed to be conducted in all state capitals in at least three session sites; Maharashtra and Kerala are likely…
Recipharm, Moderna sign deal for manufacturing, fill-finish of COVID-19 vaccines
They have reached an agreement to support formulation and fill-finish a part of the Moderna COVID-19 vaccine supply outside of the…
SEC meets to discuss EUA applications from Pfizer, SII and Bharat Biotech
To reconvene on Jan 1, 2021
Awaiting India’s approval for COVISHIELD: SII
The company made this statement after UK's approval of the Oxford-AstraZeneca COVID-19 vaccine
UK MHRA approves Oxford/AstraZeneca COVID-19 vaccine
Britain has ordered 100 million doses of the jab, with 40 million expected to be available by the end of March